Perioperative Interstitial Fluid Expansion Predicts Major Morbidity Following Pancreatic Surgery: Appraisal by Bioimpedance Vector Analysis.


Journal

Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354

Informations de publication

Date de publication:
11 2019
Historique:
pubmed: 9 10 2019
medline: 17 3 2020
entrez: 9 10 2019
Statut: ppublish

Résumé

To evaluate whether perioperative bioimpedance vector analysis (BIVA) predicts the occurrence of surgery-related morbidity. BIVA is a reliable tool to assess hydration status and compartimentalized fluid distribution. The BIVA of patients undergoing resection for pancreatic malignancies was prospectively measured on the day prior to surgery and on postoperative day (POD)1. Postoperative morbidity was scored per the Clavien-Dindo classification (CDC), and the Comprehensive Complication Index (CCI). Out of 249 patients, the overall and major complication rates were 61% and 16.5% respectively. The median CCI was 24 (IQR 0.0-24.2), and 24 patients (9.6%) had a complication burden with CCI≥40. At baseline the impedance vectors of severe complicated patients were shorter compared to the vectors of uncomplicated patients only for the female subgroup (P=0.016). The preoperative extracellular water (ECW) was significantly higher in patients who experienced severe morbidity according to the CDC or not [19.4L (17.5-22.0) vs. 18.2L (15.6-20.6), P=0.009, respectively] and CCI≥40, or not [20.3L (18.5-22.7) vs. 18.3L (15.6-20.6), P=0.002, respectively]. The hydration index on POD1 was significantly higher in patients who experienced major complications than in uncomplicated patients (P=0.020 and P=0.025 for CDC and CCI, respectively).At a linear regression model, age (β=0.14, P=0.035), sex female (β=0.40, P<0.001), BMI (β=0.30, P<0.001), and malnutrition (β=0.14, P=0.037) were independent predictors of postoperative ECW. The amount of extracellular fluid accumulation predicts major morbidity after pancreatic surgery. Female, obese and malnourished patients were at high risk of extracellular fluid accumulation.

Sections du résumé

OBJECTIVE
To evaluate whether perioperative bioimpedance vector analysis (BIVA) predicts the occurrence of surgery-related morbidity.
SUMMARY BACKGROUND DATA
BIVA is a reliable tool to assess hydration status and compartimentalized fluid distribution.
METHODS
The BIVA of patients undergoing resection for pancreatic malignancies was prospectively measured on the day prior to surgery and on postoperative day (POD)1. Postoperative morbidity was scored per the Clavien-Dindo classification (CDC), and the Comprehensive Complication Index (CCI).
RESULTS
Out of 249 patients, the overall and major complication rates were 61% and 16.5% respectively. The median CCI was 24 (IQR 0.0-24.2), and 24 patients (9.6%) had a complication burden with CCI≥40. At baseline the impedance vectors of severe complicated patients were shorter compared to the vectors of uncomplicated patients only for the female subgroup (P=0.016). The preoperative extracellular water (ECW) was significantly higher in patients who experienced severe morbidity according to the CDC or not [19.4L (17.5-22.0) vs. 18.2L (15.6-20.6), P=0.009, respectively] and CCI≥40, or not [20.3L (18.5-22.7) vs. 18.3L (15.6-20.6), P=0.002, respectively]. The hydration index on POD1 was significantly higher in patients who experienced major complications than in uncomplicated patients (P=0.020 and P=0.025 for CDC and CCI, respectively).At a linear regression model, age (β=0.14, P=0.035), sex female (β=0.40, P<0.001), BMI (β=0.30, P<0.001), and malnutrition (β=0.14, P=0.037) were independent predictors of postoperative ECW.
CONCLUSION
The amount of extracellular fluid accumulation predicts major morbidity after pancreatic surgery. Female, obese and malnourished patients were at high risk of extracellular fluid accumulation.

Identifiants

pubmed: 31592889
doi: 10.1097/SLA.0000000000003536
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

923-929

Auteurs

Marta Sandini (M)

School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Department of Surgery, San Gerardo Hospital, Monza, Italy.

Salvatore Paiella (S)

Unit of General and Pancreatic Surgery, The Pancreas Institute, Policlinico GB Rossi, University of Verona Hospital Trust, Verona, Italy.

Marco Cereda (M)

School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Department of Surgery, San Gerardo Hospital, Monza, Italy.
Pancreatic Surgery, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy.

Marco Angrisani (M)

School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Department of Surgery, San Gerardo Hospital, Monza, Italy.
Pancreatic Surgery, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy.

Giovanni Capretti (G)

Pancreatic Surgery, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy.

Fabio Casciani (F)

Unit of General and Pancreatic Surgery, The Pancreas Institute, Policlinico GB Rossi, University of Verona Hospital Trust, Verona, Italy.

Simone Famularo (S)

School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Department of Surgery, San Gerardo Hospital, Monza, Italy.

Alessandro Giani (A)

School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Department of Surgery, San Gerardo Hospital, Monza, Italy.

Linda Roccamatisi (L)

School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Department of Surgery, San Gerardo Hospital, Monza, Italy.

Elena Viviani (E)

Unit of General and Pancreatic Surgery, The Pancreas Institute, Policlinico GB Rossi, University of Verona Hospital Trust, Verona, Italy.

Riccardo Caccialanza (R)

Clinical Nutrition and Dietetics Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Marco Montorsi (M)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Department of Surgery, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy.

Alessandro Zerbi (A)

Pancreatic Surgery, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy.

Claudio Bassi (C)

Unit of General and Pancreatic Surgery, The Pancreas Institute, Policlinico GB Rossi, University of Verona Hospital Trust, Verona, Italy.

Luca Gianotti (L)

School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Department of Surgery, San Gerardo Hospital, Monza, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH